Racial/ethnic differences in telemedicine utilization and satisfaction among patients with breast cancer during the COVID-19 pandemic.

Authors

Jincong Freeman

Jincong Freeman

Department of Public Health Sciences, University of Chicago, Chicago, IL

Jincong Freeman, Fangyuan Zhao, Rita Nanda, Olufunmilayo I. Olopade, Dezheng Huo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science

Sub Track

Impact of Telemedicine

Citation

J Clin Oncol 40, 2022 (suppl 28; abstr 384)

DOI

10.1200/JCO.2022.40.28_suppl.384

Abstract #

384

Poster Bd #

E23

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

Impact of state policies on telehealth use among the privately insured with newly diagnosed cancer.

Impact of state policies on telehealth use among the privately insured with newly diagnosed cancer.

First Author: Ya-Chen Tina Shih

Poster

2021 ASCO Quality Care Symposium

The impact of COVID-19 on breast cancer care: Delays in screening.

The impact of COVID-19 on breast cancer care: Delays in screening.

First Author: Amina Dhahri

Poster

2021 ASCO Quality Care Symposium

Care at the end of life during the COVID-19 pandemic: A CancerLinQ Discovery (CLQD) analysis.

Care at the end of life during the COVID-19 pandemic: A CancerLinQ Discovery (CLQD) analysis.

First Author: Gabrielle Betty Rocque

Poster

2021 ASCO Annual Meeting

COVID-related anxiety is prevalent and accurately reflects serious COVID risks in breast cancer patients.

COVID-related anxiety is prevalent and accurately reflects serious COVID risks in breast cancer patients.

First Author: Marisa C. Weiss